Lampalizumab (Anti-Complement Factor D)

Synonyms: RG 7417; TNX 234; Anti-CFD Recombinant Antibody

Lampalizumab (Anti-Complement Factor D) is a humanised monoclonal antibody targeting complement Factor D in the alternative complement pathway. Lampalizumab binds an exosite and sterically blocks Factor B access to the active site. Lampalizumab can be used for age-related macular degeneration (AMD) research. MW: 145.5 KD.

Lampalizumab (Anti-Complement Factor D)

Purity & Quality Control

Biological Activity

Description Lampalizumab (Anti-Complement Factor D) is a humanised monoclonal antibody targeting complement Factor D in the alternative complement pathway. Lampalizumab binds an exosite and sterically blocks Factor B access to the active site. Lampalizumab can be used for age-related macular degeneration (AMD) research. MW: 145.5 KD.

Product Details

CAS No. 1278466-20-8
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Lampalizumab (Anti-Complement Factor D) | Lampalizumab (Anti-Complement Factor D) supplier | purchase Lampalizumab (Anti-Complement Factor D) | Lampalizumab (Anti-Complement Factor D) cost | Lampalizumab (Anti-Complement Factor D) manufacturer | order Lampalizumab (Anti-Complement Factor D) | Lampalizumab (Anti-Complement Factor D) distributor